As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At PIMCO Dynamic Credit Income Fund (PCI), a filing with the SEC revealed that on Tuesday, William H. Gross purchased 101,444 shares of PCI, at a cost of $23.67 each, for a total investment of $2.40M. PIMCO Dynamic Credit Income Fund is trading up about 0.3% on the day Friday. Before this latest buy, Gross bought PCI on 25 other occasions during the past twelve months, for a total cost of $57.85M at an average of $23.18 per share.
And at RXI Pharmaceuticals (RXII), there was insider buying on Wednesday, by CEO Geert Cauwenbergh who purchased 1,400 shares for a cost of $2.57 each, for a total investment of $3,598. Before this latest buy, Cauwenbergh purchased RXII at 33 other times during the past twelve months, for a total cost of $68,709 at an average of $3.39 per share. RXI Pharmaceuticals is trading trading flat on the day Friday. Bargain hunters are able to pick up RXII at a price even lower than Cauwenbergh did, with the stock trading as low as $2.48 in trading on Friday -- that's 3.5% below Cauwenbergh's purchase price.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.